Genetic Technologies Reports Q1 FY22 Results : vimarsana.com

Genetype MultiTest submitted for regulatory approval as commercialization plans gather momentum increase in cash receipts over prior quarter ...

Related Keywords

Australia , Melbourne , Victoria , United States , United Kingdom , Australian , American , Biobank Gafni , Simon Morriss , Predictive Panel Risk Test , Institute Of Public Health In St Louis , Company Multi , Genetic Technologies Limited , Nasdaq , Technologies Limited , Breast Cancer , Colorectal Cancer , Prostate Cancer , Ovarian Cancer , Coronary Artery Disease , African American , Public Health , Genetic Technologies , Australian Stock Exchange Gtg Ax , Genetic Technologies Ltd ,